Answers are grounded in this paper and cite their sources.
Oculomics uses ocular characteristics as potential biomarkers of systemic health. Combined with artificial intelligence (AI), it offers new opportunities for cardiovascular risk assessment. This study aims to analyze the applications of oculomics and AI in identifying ocular biomarkers associated with cardiovascular risk, highlighting their potential and limitations. This literature review examines retinal biomarkers, fundus photography, optical coherence tomography (OCT), optical coherence tomography angiography (OCTA), and AI-based computational models. The available evidence indicates that AI algorithms can identify retinal vascular and structural patterns associated with hypertension, diabetes mellitus, and cardiovascular conditions, supporting their potential use in risk stratification. However, detecting existing disease must be distinguished from predicting future cardiovascular events. Limited external validation, algorithmic interpretability, population representativeness, implementation costs, and data privacy remain sig nificant challenges. In conclusion, oculomics combined with AI represents a promising noninvasive approach to cardiovascular assessment and precision medicine. Nevertheless, further prospective studies and independent validation are required to establish its clinical utility and support broader implementation.
No takes yet. Share an insight, caveat, or question.
Anjos et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: